Lonza Aktie
WKN: 928619 / ISIN: CH0013841017
25.07.2024 06:55:16
|
Lonza Group H1 2024 Performance Well On Track to Deliver Full-Year Outlook: Sales Up 1.8% CER and 29.2% CORE EBITDA Margin
Lonza Group AG / Key word(s): Half Year Results Ad hoc announcement pursuant to Art. 53 LR
Group Financial Summary
For more details on performance and financials, please refer to the Half-Year 2024 Presentation, Half-Year 2024 Report and Alternative Performance Measures (APM) 2024 Report.
1 Sales growth figures, expressed as a percentage (%), are at Constant Exchange Rate (CER) About Lonza Lonza is one of the world’s largest healthcare manufacturing organizations. Working across five continents, our global community of around 18,000 colleagues helps pharmaceutical, biotech and nutrition companies to bring their treatments to market. United by our vision to bring any therapy to life, we support our customers with a combination of technological insight, world-class manufacturing, scientific expertise, process excellence and innovation. Our work enables our customers to develop and commercialize their therapeutic discoveries, allowing their patients to benefit from life-saving and life-enhancing treatments. Our business is structured to meet our customers' complex needs across four divisions: Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients. Our company generated sales of CHF 3.1 billion with a CORE EBITDA of CHF 893 million in Half-Year 2024. Find out more at www.lonza.com Lonza Contact Details Victoria Morgan Head of External Communications Daniel Buchta End of Inside Information |
Language: | English |
Company: | Lonza Group AG |
Münchensteinerstrasse 38 | |
4052 Basel | |
Switzerland | |
Phone: | +4161 316 81 11 |
Internet: | www.lonza.com |
ISIN: | CH0013841017 |
Valor: | 1384101 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1953479 |
End of Announcement | EQS News Service |
|
1953479 25-Jul-2024 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Lonza AG (N)mehr Nachrichten
01.04.25 |
Handel in Zürich: SMI nachmittags mit Kursplus (finanzen.at) | |
01.04.25 |
Lonza Implements its Simplified and Streamlined Operating Model (EQS Group) | |
01.04.25 |
Zuversicht in Zürich: SLI am Mittag mit grünem Vorzeichen (finanzen.at) | |
01.04.25 |
Aufschläge in Zürich: SMI mittags auf grünem Terrain (finanzen.at) | |
01.04.25 |
Freundlicher Handel: Börsianer lassen SMI zum Start steigen (finanzen.at) | |
01.04.25 |
Lonza Completes its Share Buyback Program (EQS Group) | |
28.03.25 |
Schwacher Wochentag in Zürich: Das macht der SMI nachmittags (finanzen.at) | |
27.03.25 |
SMI-Papier Lonza-Aktie: So viel Gewinn hätte ein Lonza-Investment von vor 10 Jahren abgeworfen (finanzen.at) |
Analysen zu Lonza AG (N)mehr Analysen
Aktien in diesem Artikel
Lonza AG (N) | 294,00 | -0,24% |
|